Enlarged choroid plexus related to iron rim lesions and deep gray matter atrophy in relapsing-remitting multiple sclerosis.

[1]  Yongmei Li,et al.  Enlarged choroid plexus related to cortical atrophy in multiple sclerosis , 2022, European Radiology.

[2]  C. Louapre,et al.  Imaging Characteristics of Choroid Plexuses in Presymptomatic Multiple Sclerosis , 2022, Neurology: Neuroimmunology & Neuroinflammation.

[3]  A. Klistorner,et al.  Choroid plexus volume in multiple sclerosis predicts expansion of chronic lesions and brain atrophy , 2022, Annals of clinical and translational neurology.

[4]  C. Constantinescu,et al.  Longitudinal clinical study of patients with iron rim lesions in multiple sclerosis , 2022, Multiple sclerosis.

[5]  C. Granziera,et al.  Choroid Plexus Volume in Multiple Sclerosis vs Neuromyelitis Optica Spectrum Disorder , 2022, Neurology: Neuroimmunology & Neuroinflammation.

[6]  F. Barkhof,et al.  Relationship Between White Matter Lesions and Gray Matter Atrophy in Multiple Sclerosis , 2022, Neurology.

[7]  A. Klistorner,et al.  The expansion and severity of chronic MS lesions follows a periventricular gradient , 2021, medRxiv.

[8]  O. Stüve,et al.  Choroid plexus volumetrics and brain inflammation in multiple sclerosis , 2021, Proceedings of the National Academy of Sciences.

[9]  D. Reich,et al.  A lymphocyte–microglia–astrocyte axis in chronic active multiple sclerosis , 2021, Nature.

[10]  V. Fleischer,et al.  Translational value of choroid plexus imaging for tracking neuroinflammation in mice and humans , 2021, Proceedings of the National Academy of Sciences.

[11]  C. Louapre,et al.  Choroid Plexus Enlargement in Inflammatory Multiple Sclerosis: 3.0-T MRI and Translocator Protein PET Evaluation. , 2021, Radiology.

[12]  Vito A G Ricigliano,et al.  Structural and Clinical Correlates of a Periventricular Gradient of Neuroinflammation in Multiple Sclerosis , 2021, Neurology.

[13]  G. Kasprian,et al.  Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI. , 2021, Brain : a journal of neurology.

[14]  V. Leavitt.  The SDMT is not information processing speed , 2021, Multiple sclerosis.

[15]  H. Jin,et al.  The blood cerebrospinal fluid barrier orchestrates immunosurveillance, immunoprotection, and immunopathology in the central nervous system , 2020, BMB reports.

[16]  Maria K. Lehtinen,et al.  Inflammation of the Embryonic Choroid Plexus Barrier following Maternal Immune Activation. , 2020, Developmental cell.

[17]  J. DeLuca,et al.  Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues , 2020, The Lancet Neurology.

[18]  Bryan R. Smith,et al.  Paramagnetic Rim Lesions are Specific to Multiple Sclerosis: An International Multicenter 3T MRI Study , 2020, Annals of neurology.

[19]  À. Rovira,et al.  Value of 3T Susceptibility-Weighted Imaging in the Diagnosis of Multiple Sclerosis , 2020, American Journal of Neuroradiology.

[20]  R. Bruggmann,et al.  Altered secretory and neuroprotective function of the choroid plexus in progressive multiple sclerosis , 2020, Acta Neuropathologica Communications.

[21]  A. Korczyn,et al.  The temporal and causal relationship between inflammation and neurodegeneration in multiple sclerosis , 2020, Multiple sclerosis.

[22]  A. C. Duarte,et al.  The choroid plexus: Simple structure, complex functions , 2019, Journal of neuroscience research.

[23]  A. Gass,et al.  Characterization of Contrast-Enhancing and Non-contrast-enhancing Multiple Sclerosis Lesions Using Susceptibility-Weighted Imaging , 2019, Front. Neurol..

[24]  R. Reynolds,et al.  Meningeal inflammation and cortical demyelination in acute multiple sclerosis , 2018, Annals of neurology.

[25]  M. Filippi,et al.  Multiple sclerosis , 2018, Nature Reviews Disease Primers.

[26]  J. Ghersi-Egea,et al.  Molecular anatomy and functions of the choroidal blood-cerebrospinal fluid barrier in health and disease , 2018, Acta Neuropathologica.

[27]  David H. Miller,et al.  Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria , 2017, The Lancet Neurology.

[28]  Guo Yong,et al.  Pathogenic implications of distinct patterns of iron and zinc in chronic MS lesions , 2017, Acta Neuropathologica.

[29]  Siegfried Trattnig,et al.  Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging , 2016, Acta Neuropathologica.

[30]  H. Hartung,et al.  Dimethyl fumarate in relapsing–remitting multiple sclerosis: rationale, mechanisms of action, pharmacokinetics, efficacy and safety , 2015, Expert review of neurotherapeutics.

[31]  Thomas Kohlmann,et al.  Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis , 2013, BMC Neurology.

[32]  J. Ghersi-Egea,et al.  Brain leukocyte infiltration initiated by peripheral inflammation or experimental autoimmune encephalomyelitis occurs through pathways connected to the CSF-filled compartments of the forebrain and midbrain , 2012, Journal of Neuroinflammation.

[33]  Bernhard Hemmer,et al.  An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis , 2012, NeuroImage.

[34]  A. Compston,et al.  Multiple sclerosis , 2008, The Lancet.

[35]  Alberto Romagnolo,et al.  Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: A neuropathological study , 2008, Journal of Neuroimmunology.